Omega-3 fatty acids: Investigations from cytokine regulation to pancreatic cancer gene suppression

Archives of Surgery

Volumn 145, Issue 6, 2010, Pages 515-520

  Boutros, Cherif ^a   Somasundar, Ponnandai ^a   Razzak, Anthony ^a   Helton, Scott ^b   Espat, N Joseph ^a  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL CYCLE ARREST; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME INACTIVATION; GENE REPRESSION; HUMAN; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PRIMARY PREVENTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 77953863359     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.91     Document Type: Review

References (60)

1. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83(3):217-244.
2. Booyens J, van der Merwe CF, Katzeff IE. Chronic arachidonic acid eicosanoid imbalance: a common feature in coronary artery disease, hypercholesterolemia, cancer and other important diseases: significance of desaturase enzyme inhibition and of the arachidonic acid desaturase-independent pathway. Med Hypotheses. 1985;18(1):53-60.
3. Meydani SN, Meydani M, Verdon CP, Shapiro AA, Blumberg JB, Hayes KC. Vitamin E supplementation suppresses prostaglandin E1(2) synthesis and enhances the immune response of aged mice. Mech Ageing Dev. 1986;34(2):191-201.
4. Siscovick DS, Raghunathan T, King I, et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 2000;71(1)(suppl):208S-212S.
5. von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids: a comprehensive strategy. Ann Intern Med. 1987;107(6):890-899.
6. Barton RG, Wells CL, Carlson A, Singh R, Sullivan JJ, Cerra FB. Dietary omega-3 fatty acids decrease mortality and Kupffer cell prostaglandin E2 production in a rat model of chronic sepsis. J Trauma. 1991;31(6):768-774.
7. Lo C-J, Terasaki M, Garcia R, Helton S. Fish oil-supplemented feeding does not attenuate warm liver ischemia and reperfusion injury in the rat. J Surg Res. 1997; 71(1):54-60.
8. Lokesh BR, Kinsella JE. Modulation of prostaglandin synthesis in mouse peritoneal macrophages by enrichment of lipids with either eicosapentaenoic or docosahexaenoic acids in vitro. Immunobiology. 1987;175(5):406-419.
9. Billiar TR, Bankey PE, Svingen BA, et al. Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery. 1988;104(2):343-349.
10. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320(5):265-271. (Pubitemid 19045549)
11. Zheng ZM, Specter SC, Lancz G. Bovine serum albumin preparations enhance in vitro production of tumor necrosis factor alpha by murine macrophages. Immunol Invest. 1995;24(5):737-756.
12. Morlion BJ, Torwesten E, Lessire H, et al. The effect of parenteral fish oil on leukocyte membrane fatty acid composition and leukotriene-synthesizing capacity in patients with postoperative trauma. Metabolism. 1996;45(10):1208- 1213.
13. Roulet M, Frascarolo P, Pilet M, Chapuis G. Effects of intravenously infused fish oil on platelet fatty acid phospholipid composition and on platelet function in postoperative trauma. JPEN J Parenter Enteral Nutr. 1997;21(5):296-301. (Pubitemid 27408649)
14. Babcock TA, Helton WS, Hong D, Espat NJ. Omega-3 fatty acid lipid emulsion reduces LPS-stimulated macrophage TNF-α production. Surg Infect (Larchmt). 2002;3(2):145-149.
15. Reich R, Royce L, Martin GR. Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells. Biochem Biophys Res Commun. 1989;160(2):559-564.
16. Abdi-Dezfuli F, Frøyland L, Thorsen T, Aakvaag A, Berge RK. Eicosapentaenoic acid and sulphur substituted fatty acid analogues inhibit the proliferation of human breast cancer cells in culture. Breast Cancer Res Treat. 1997;45(3):229-239.
17. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54(3):438-463.
18. Mukutmoni-Norris M, Hubbard NE, Erickson KL. Modulation of murine mammary tumor vasculature by dietary n-3 fatty acids in fish oil. Cancer Lett. 2000; 150(1):101-109. (Pubitemid 30123054)
19. Braden LM, Carroll KK. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids. 1986;21(4):285-288. (Pubitemid 16108259)
20. Gabor H, Abraham S. Effect of dietary menhaden oil on tumor cell loss and the accumulation of mass of a transplantable mammary adenocarcinoma in BALB/c mice. J Natl Cancer Inst. 1986;76(6):1223-1229. (Pubitemid 16093160)
21. Rose DP, Connolly JM, Rayburn J, Coleman M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst. 1995;87(8):587-592.
22. Hubbard NE, Lim D, Erickson KL. Alteration of murine mammary tumorigenesis by dietary enrichment with n-3 fatty acids in fish oil. Cancer Lett. 1998;124 (1):1-7.
23. Park Y, Allen KG, Shultz TD. Modulation of MCF-7 breast cancer cell signal transduction by linoleic acid and conjugated linoleic acid in culture. Anticancer Res. 2000;20(2A):669-676. (Pubitemid 30240617)
24. Lo C-J, Chiu KC, Fu M, Lo R, Helton S. Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. J Surg Res. 1999;86(1):103-107.
25. Dempke W, Rie C, Grothey A, Schmoll H-J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol. 2001;127(7):411-417.
26. Tevar R, Jho DH, Babcock T, Helton WS, Espat NJ. Omega-3 fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr. 2002;26(5):285-289. (Pubitemid 34913116)
27. Jho DH, Babcock TA, Tevar R, Helton WS, Espat NJ. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr. 2002;26(5):291-297. (Pubitemid 34913118)
28. Hwang D, Rhee SH. Receptor-mediated signaling pathways: potential targets of modulation by dietary fatty acids. Am J Clin Nutr. 1999;70(4):545-556. (Pubitemid 29463450)
29. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr. 2003;27(1):52-57.
30. Babcock TA, Kurland A, Helton WS, Rahman A, Anwar KN, Espat NJ. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. JPEN J Parenter Enteral Nutr. 2003;27(3):176-181. (Pubitemid 36547305)
31. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-κ B inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am J Physiol Lung Cell Mol Physiol. 2003;284(1):L84-L89.
32. Baeuerle PA, Baltimore D. NF-κ B: ten years after. Cell. 1996;87(1):13-20.
33. Baldwin AS Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
34. Baeuerle PA, Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell. 1988;53(2):211-217.
35. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988;242(4878):540-546.
36. Beg AA, Baldwin AS Jr. The I kappa B proteins: multifunctional regulators of Rel/ NF-kappa B transcription factors. Genes Dev. 1993;7(11):2064-2070. (Pubitemid 2010879) (Pubitemid 23336134)
37. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343(5):338-344.
38. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 1996;84(6):853-862.
39. Traenckner EB, Pahl HL, Henkel T, Schmidt KN,Wilk S, Baeuerle PA. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 1995;14(12):2876-2883.
40. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 1997;91(2):243-252.
41. Lo C-J, Chiu KC, Fu M, Lo R, Helton S. Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NFκB activity. J Surg Res. 1999; 82(2):216-221.
42. Bégin ME, Ells G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986;77(5):1053-1062. (Pubitemid 17184127)
43. Jordan A, Stein J. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr. 2003;42(6):324-331. (Pubitemid 38055612)
44. Sharma A, Belna J, Logan J, Espat J, Hurteau JA. The effects of ω-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol Oncol. 2005;99(1):58-64.
45. Falconer JS, Ross JA, Fearon KC, Hawkins RA, O'Riordain MG, Carter DC. Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer. 1994;69(5):826-832.
46. Jordan A, Stein J. Modulation of epidermal growth factor-induced cell proliferation by an ω-3 fatty-acid-containing lipid emulsion on human pancreatic cancer cell line Mia Paca-2. Nutrition. 2001;17(6):474-475.
47. Dekoj T, Lee S, Desai S, et al. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model. J Surg Res. 2007;139(1):106-112.
48. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell. 1999;98(3):295-303.
49. Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10(1):105-115.
50. Garcia R, Jove R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci. 1998;5(2):79-85. (Pubitemid 28253097)
51. Garcea G, Dennison AR, Steward WP, Berry DP. Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology. 2005;5(6):514-529.
52. Arlt A, Gehrz A, Müerköster S, et al. Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene. 2003;22(21):3243-3251.
53. Falconer JS, Fearon KC, Ross JA, Carter DC. Polyunsaturated fatty acids in the treatment of weight-losing patients with pancreatic cancer. World Rev Nutr Diet. 1994;76:74-76.
54. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000;36(2):177-184.
55. Fearon KCH, von Meyenfeldt MF, Moses AGW, et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52(10):1479-1486.
56. Lai PB, Ross JA, Fearon KC, Anderson JD, Carter DC. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer. 1996;74(9):1375-1383.
57. Babcock TA, Novak T, Ong E, Jho DH, Helton WS, Espat NJ. Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res. 2002;107(1):135-139. (Pubitemid 35191824)
58. Schniewind B, Christgen M, Kurdow R, et al. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis. Int J Cancer. 2004;109(2):182-188.
59. Shi X, Liu S, Kleeff J, Friess H, Büchler MW. Acquired resistance of pancreatic cancer cells towards 5-fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology. 2002;62(4):354-362.
60. Ross JA, Maingay JP, Fearon KC, Sangster K, Powell JJ. Eicosapentaenoic acid perturbs signalling via the NFkappaB transcriptional pathway in pancreatic tumour cells. Int J Oncol. 2003;23(6):1733-1738.